SCHEMBL5317263

SCHEMBL5317263

O=C(OCl)C1CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1026427 0.94
SCHEMBL1584170 0.92 CES2 (0.50)
SCHEMBL3645869 0.88
SCHEMBL14488967 0.80 HTT (0.33)
SCHEMBL6925922 0.80 AAK1 (0.35)
SCHEMBL2201861 0.79 SMN1; SMN2 (0.54)
SCHEMBL12174861 0.79 HTT (0.31)
SCHEMBL12174860 0.79 LMNA (0.43)
SCHEMBL17895344 0.77 PIK3CD (0.32)
SCHEMBL2056468 0.77 GABRA1 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3638227-A1 SPIROCYCLIC INDOLINES AS IL-17 MODULATORS UCB Biopharma SRL (BE) 2020-04-22 EP disclosed
WO-2018229079-A1 SPIROCYCLIC INDOLINES AS IL-17 MODULATORS UCB BIOPHARMA SPRL (BE) 2018-12-20 WO disclosed
WO-2007146695-A1 ACYCLIC OXIMYL HEPATITIS C PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2007-12-21 WO disclosed
US-4431665-A Acylated laidlomycin derivatives SYNTEX (U.S.A.) INC. (US) 1984-02-14 US disclosed
EP-0024189-B1 ACYLATED LAIDLOMYCIN DERIVATIVES, THEIR PREPARATION AND COMPOSITIONS SYNTEX (U.S.A.) INC. (US) 1983-03-02 EP disclosed
EP-0024189-A1 Acylated laidlomycin derivatives, their preparation and compositions SYNTEX (U.S.A.) INC. (US) 1981-02-25 EP disclosed